| Wood Family Eye Care, L.l.c | |
|
64 4th Avenue, Ashville, AL 35953 | |
| (205) 594-3168 | |
| Not Available |
| Full Name | Wood Family Eye Care, L.l.c |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 64 4th Avenue, Ashville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740515444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | SB54TA775 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wood Family Eye Care, L.l.c 741 Macdonald Lake Rd, Springville, AL 35146-3858 Ph: (901) 827-5925 | Wood Family Eye Care, L.l.c 64 4th Avenue, Ashville, AL 35953 Ph: (205) 594-3168 |
News Archive
Authorities scramble to provide drugs to treat a fungal disease affecting India's COVID-19 patients. A fungal disease called mucormycosis is emerging among hundreds of COVID-19 patients in India, placing further strain on hospitals already at breaking point.
Patients undergoing long-term dialysis, especially Black and Hispanic patients and those living in nursing homes, were severely impacted by the COVID-19 pandemic, according to a nationwide study by University of Michigan researchers.
Womanhood definitely has its advantages—studies even show we live longer than men—but menopause isn't on the list of perks. Sometime between the ages of 40-58, our bodies will inevitably experience a drop in estrogen production and begin a metamorphosis.
Amie Goins has completed eight 5K runs in 2018. An impressive feat for a 46-year-old mother with a full-time job and two teenage sons to care for – downright astounding for a woman who was diagnosed with stage 2 breast cancer two days before Christmas last year. She's conquered months of treatment and difficult side effects while continuing to lace up.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
› Verified 3 days ago
Dr. Shonda Hopkins Wood, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 64 4th Avenue, Ashville, AL 35953 Phone: 205-594-3168 Fax: 256-593-1031 |